Bio-Rad Laboratories (BIO) earnings, Nov 4, 2026: EPS +17%, stock −2.9%
In brief
Bio-Rad Laboratories reported on Nov 4, 2026. Earnings per share changed +17% year over year, 19.0% above the estimate; revenue +1%. The stock opened with a −3.3% gap and closed the day −2.9% (Nov 5, 2026). The stock is now 6.9% below its 52-week high, +19.0% over 12 months. Next report: Feb 18, 2027.
EPS vs estimate+19.0%
EPS, YoY+17%
Revenue, YoY+1%
Gap · day−3.3% · −2.9%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | +2.1% | +4.5% |
| Nov 4, 2026 | −3.3% | −2.9% |
Next-quarter estimates, ratings and the BIO chart are in the terminal.
Open the terminalFAQ
When is Bio-Rad Laboratories's next earnings report?
Feb 18, 2027. The date comes from daily data and is corrected if the company moves it.
How did Bio-Rad Laboratories stock react to the report?
Opening gap −3.3%, day's result −2.9%.
Did Bio-Rad Laboratories's earnings grow?
Earnings per share rose 17% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.